Cervical canal

Maria Milian Sobarzo, MD, FACOG is recognized by Continental Who's Who

Retrieved on: 
Friday, August 20, 2021
Continental, Birth, University, DYSI, Cervical canal, Medicine, Arkansas, United States Congress, Laparoscopy, Singing, Hysteroscopy, Menopause, Vagina, Hormone replacement therapy, LEEP, Running, Classic Hits Live/Best of Live, Reproductive health, FACOG, Trust (social science), OBGYN, Vulva, Health, Samuel, Multimedia, Houston Methodist West Hospital, Living Water, Volunteering, Make-A-Wish Foundation, Patient, Cryotherapy, Memorial Hermann Katy Hospital, Wellness, Colposcopy, IUD, Texas A&M University, Uterine fibroid, Cyst, Technology, 2000 Teen Choice Awards, MD, Birth control

KATY, Texas, Aug. 20, 2021 /PRNewswire/ -- Maria Milian Sobarzo, MD, FACOG, is being recognized by Continental Who's Who as a Trusted OBGYN for her many years of outstanding service in the field of Obstetrics and Gynecology.

Key Points: 
  • KATY, Texas, Aug. 20, 2021 /PRNewswire/ -- Maria Milian Sobarzo, MD, FACOG, is being recognized by Continental Who's Who as a Trusted OBGYN for her many years of outstanding service in the field of Obstetrics and Gynecology.
  • Dr. Sobarzo originally worked in Obstetrics and Gynecology for over 25 years, but realized she wanted to focus primarily on Gynecology.
  • She is a passionate advocate for reproductive health, and will do everything she can to help her patients feel their best.
  • She has extensive experience with women's health issues, including routine examinations, contraception, laparoscopy, menopause, uterine fibroids, ovarian cysts, and other issues.

CrossBay Medical Receives FDA Clearance for CrossGlide Endometrial Tissue Sampler

Retrieved on: 
Wednesday, April 1, 2020
Medical devices, FDA, Health, Consumer, Women, Baby, Maternity, Mammal female reproductive system, Medicine, Biopsy, Medical specialties, Pelvis, Clinical medicine, Women's health, Endometrial biopsy, Human female reproductive system, Uterus, Endometrium, Cervical canal

CrossBay Medical, Inc., a health technology company focused on improving the delivery of womens healthcare, today announced it has received clearance from the Food and Drug Administration (FDA) to market its CrossGlide ETS Endometrial Tissue Sampler.

Key Points: 
  • CrossBay Medical, Inc., a health technology company focused on improving the delivery of womens healthcare, today announced it has received clearance from the Food and Drug Administration (FDA) to market its CrossGlide ETS Endometrial Tissue Sampler.
  • The CrossGlide ETS, the third product to utilize the frictionless CrossGlide technology platform, enables medical providers to perform an office-based endometrial biopsy procedure gently, effortlessly and without a tenaculum.
  • In today's typical practice, a medical provider will try to push a pipelle across the cervical canal to access the uterus.
  • CrossBay also serves as a strategic innovation partner to large medical device firms interested in incorporating the companys game-changing CrossGlide technology into their suites of patient-friendly product offerings.